D. H. Kwon, “Corrigendum to ‘Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway’ [EXCLI Journal 2021;20:968-982]”, EXCLI J., vol. 24, pp. 452–453, Mar. 2025.